Date published: 2025-10-25

001 800-1338-3838

SCBT Portrait Logo
Seach Input

LIN-35 アクチベーター

Assuming "LIN-35" refers to a protein or gene that is integral to a particular biological process, activators of LIN-35 would be molecules that enhance its biological activity. These activators could potentially work by binding directly to the LIN-35 protein, inducing a conformational change that results in increased activity, or by facilitating its interaction with other proteins or substrates. The chemical structures of LIN-35 activators would likely be diverse, as they would need to possess specific characteristics that enable them to interact with distinct structural motifs or domains within LIN-35. These characteristics could include particular arrangements of atoms, charged groups, hydrophobic or hydrophilic elements, or even larger molecular frameworks for protein-protein interaction modulation.

In the realm of research, scientists investigating LIN-35 activators would employ a variety of techniques to understand the interaction between these molecules and the LIN-35 protein. Studies might include computational modeling to predict how these activators could bind to the protein and what effects they may exert on its structure and function. Experimental approaches would likely involve the use of in vitro assays to assess the biochemical consequences of activator binding, such as changes in the enzymatic activity of LIN-35 or alterations in its ability to interact with other cellular components. Advanced analytical techniques like mass spectrometry, circular dichroism, and fluorescence spectroscopy could provide insights into the binding dynamics and structural changes. Furthermore, if the precise structure of the LIN-35 protein were known, techniques such as X-ray crystallography or cryo-electron microscopy might be used to solve the structure of the protein in complex with activator molecules, giving a clear picture of the molecular interactions at play. This could elucidate the mechanism by which these activators enhance LIN-35 activity. Nonetheless, without concrete scientific evidence to define "LIN-35 Activators," this discussion remains purely theoretical and is not grounded in any known chemical classification.

関連項目

製品名CAS #カタログ #数量価格引用文献レーティング

Hydroxyurea

127-07-1sc-29061
sc-29061A
5 g
25 g
$76.00
$255.00
18
(1)

ヒドロキシ尿素はDNA損傷を誘発し、細胞周期制御タンパク質に影響を与え、ストレス反応の一部としてLIN-35の発現を変化させる可能性がある。

Camptothecin

7689-03-4sc-200871
sc-200871A
sc-200871B
50 mg
250 mg
100 mg
$57.00
$182.00
$92.00
21
(2)

カンプトテシンは、トポイソメラーゼIを阻害することによってDNA損傷を誘導し、細胞応答としてLIN-35発現の変化を引き起こす可能性がある。

Etoposide (VP-16)

33419-42-0sc-3512B
sc-3512
sc-3512A
10 mg
100 mg
500 mg
$32.00
$170.00
$385.00
63
(1)

エトポシドはトポイソメラーゼII阻害を介してDNA鎖切断を引き起こし、DNA損傷応答中のLIN-35発現に影響を与える可能性がある。

Roscovitine

186692-46-6sc-24002
sc-24002A
1 mg
5 mg
$92.00
$260.00
42
(2)

ロスコビチンはサイクリン依存性キナーゼ阻害剤であり、潜在的にLIN-35を含む細胞周期制御因子に影響を与える可能性がある。

Aphidicolin

38966-21-1sc-201535
sc-201535A
sc-201535B
1 mg
5 mg
25 mg
$82.00
$300.00
$1082.00
30
(3)

アフィジコリンはDNAポリメラーゼ阻害剤であり、細胞周期チェックポイント活性化の一環としてLIN-35発現の変化を引き起こす可能性がある。

Taxol

33069-62-4sc-201439D
sc-201439
sc-201439A
sc-201439E
sc-201439B
sc-201439C
1 mg
5 mg
25 mg
100 mg
250 mg
1 g
$40.00
$73.00
$217.00
$242.00
$724.00
$1196.00
39
(2)

パクリタキセルは微小管を安定化させ、細胞を有糸分裂で停止させ、その過程でLIN-35の発現に影響を与える可能性がある。

Thymidine

50-89-5sc-296542
sc-296542A
sc-296542C
sc-296542D
sc-296542E
sc-296542B
1 g
5 g
100 g
250 g
1 kg
25 g
$48.00
$72.00
$265.00
$449.00
$1724.00
$112.00
16
(1)

チミジンは、高濃度で使用されるとS期における細胞周期のブロックを引き起こし、LIN-35の発現に影響を与える可能性がある。

Methotrexate

59-05-2sc-3507
sc-3507A
100 mg
500 mg
$92.00
$209.00
33
(5)

メトトレキサートはジヒドロ葉酸還元酵素を阻害し、S期停止に導くが、これはLIN-35のような細胞周期制御因子の発現に影響を与えるかもしれない。

Nocodazole

31430-18-9sc-3518B
sc-3518
sc-3518C
sc-3518A
5 mg
10 mg
25 mg
50 mg
$58.00
$83.00
$140.00
$242.00
38
(2)

ノコダゾールは微小管の重合を阻害し、細胞周期の停止をもたらすが、これはLIN-35の発現レベルに影響を与える可能性がある。

Cisplatin

15663-27-1sc-200896
sc-200896A
100 mg
500 mg
$76.00
$216.00
101
(4)

シスプラチンはDNA付加体を形成し、DNA損傷反応の活性化につながり、細胞反応の一部としてLIN-35の発現に影響を及ぼす可能性がある。